Bard Peripheral Vascular
US Vascular
PRODUCTS
PRODUCT REIMBURSEMENT
PRODUCT INDEX
PRODUCT CATALOG
CONVENTIONS
EDUCATION
SITE MAP
WHAT'S NEW
PRESS RELEASE WEB SITE


[HOME] [ABOUT BPV] [CAREERS] [CONTACT US] [US NON-VASCULAR] [OUTSIDE US] [BARD BIOPSY] [BPV OEM] [CR BARD]
 
Lifestent Vascular Graft
LifeStentBrochureIFUProduct Specs
Lifestent Vascular Stent

Resilient Trial A RandomizEd Study Comparing the Self-ExpandIng
LifeStent vs. Angioplasty-Alone In LEsions INvolving
The SFA and/or Proximal Popliteal Artery

Trial Demographics
  • 206 Patients Enrolled: 72 in PTA group, 134 in PTA and LIFESTENT® group
  • 24 Study Sites
  • Number of stents implanted: 325
     Primary Patency Rates
     Freedom from TLR
Multi-Dimensional
Helical Architecture
potentially contributed to
the low observed rates
of stent fracture
     Stent Fracture Rate
 
Please consult product labels and package inserts for indications,
contraindications, hazards, warnings, cautions, and information for use.
.
Bard and LifeStent are trademarks and/or registered trademarks of
C. R. Bard, Inc.
© 2008 C. R. Bard, Inc. All Rights Reserved. Terms of Use — Privacy Policy